| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |